2024-03-14 13:30:17 ET
Image source: The Motley Fool.
Agenus (NASDAQ: AGEN)
Q4 2023 Earnings Call
Mar 14, 2024 , 8:30 a.m. ET
Operator
For further details see:
Agenus (AGEN) Q4 2023 Earnings Call Transcript2024-03-14 13:30:17 ET
Image source: The Motley Fool.
Agenus (NASDAQ: AGEN)
Q4 2023 Earnings Call
Mar 14, 2024 , 8:30 a.m. ET
Operator
For further details see:
Agenus (AGEN) Q4 2023 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Extended BOT/BAL Therapy Yields Pronounced Improvements in Tumor Reductions Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced results from an investigator-sponsored trial (IST) of botensilim...
Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced that the Cancer Therapy Evaluation Program (CTEP) is accepting Letters of Intent (LOIs) to conduct clinical studies using botensilimab (BOT), a huma...
2024-06-27 01:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...